5
Total investments
1
Early stage
0
Mid stage
1
Late stage
4y
Years active
Portfolio
3 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor/Advisor
Oct 2024
Enquire AI fuses global expert intelligence with multi-model LLM orchestration to deliver decision-ready answers, faster, smarter, and more reliable than traditional research.
We remove the bottlenecks of legacy expert networks and static research. Ask any high-value question and get structured expert responses, AI-led interviews, and synthesized insights, delivered in hours, not weeks.
Built for capital markets, consulting, and strategy teams who can’t afford to wait.
Are you an industry leader? Join our expert network and become part of an exclusive community. Build relationships, rapidly share knowledge and be well-rewarded for your insights. Start earning today!
Advisor/Investor
Oct 2024
Syndicate Bio is a platform biotech driving genomics and precision medicine initiatives across the world’s most diverse regions.
We use large scale partnerships with governments and other stakeholders to drive local precision medicine impact while creating powerful datasets that can be used for drug discovery and development.
Investor
Dec 2023
The fight against cancer needs new, big, bold ideas. At Siren, we’ve got one: Universal AAV Immuno-Gene Therapy.
We are combining two transformative therapeutic technologies – AAV gene therapy and cytokine immunotherapy - into a single, reimagined modality that overcomes key challenges and redefines how we destroy tumor cells and elicit anti-tumor immunity.
Experience · 9 entries
All (9)
Investments (4)
Founder (2)
2024
Investor/Advisor
Oct 2024
Enquire AI fuses global expert intelligence with multi-model LLM orchestration to deliver decision-ready answers, faster, smarter, and more reliable than traditional research.
We remove the bottlenecks of legacy expert networks and static research. Ask any high-value question and get structured expert responses, AI-led interviews, and synthesized insights, delivered in hours, not weeks.
Built for capital markets, consulting, and strategy teams who can’t afford to wait.
Are you an industry leader? Join our expert network and become part of an exclusive community. Build relationships, rapidly share knowledge and be well-rewarded for your insights. Start earning today!
Advisor/Investor
Oct 2024
Syndicate Bio is a platform biotech driving genomics and precision medicine initiatives across the world’s most diverse regions.
We use large scale partnerships with governments and other stakeholders to drive local precision medicine impact while creating powerful datasets that can be used for drug discovery and development.
Founder & Managing Partner
Sep 2024
StoryVenture is a thought leadership and geo-strategic communications advisory that helps organizations take control of their narrative. Thought leadership is the new advertising. The best thought leadership explains, teaches and builds authority around issues important to your mission, and those larger than you. Most importantly, in an always-on, attention-challenged world, thought leadership is one of the last-remaining beachheads for building trust.
Expert-In-Residence, Georgetown Venture Lab
Mar 2024
Georgetown University is the oldest and largest Catholic and Jesuit university in America. Georgetown today is a major student-centered, international research university, offering programs in Washington, DC; Doha, Qatar; and around the world.
2023
Investor
Dec 2023
The fight against cancer needs new, big, bold ideas. At Siren, we’ve got one: Universal AAV Immuno-Gene Therapy.
We are combining two transformative therapeutic technologies – AAV gene therapy and cytokine immunotherapy - into a single, reimagined modality that overcomes key challenges and redefines how we destroy tumor cells and elicit anti-tumor immunity.
Show all 9 entries ↓
Investment activity
2022–2024 · 5 investments
Recent (last 2 years)Earlier
